Sanofi's pharmaceutical profit falls 42.2% by September to five billion

Sanofi reported a 42.2% drop in net profit for the first nine months of the year, totaling €4.979 billion. This decline is attributed to non-recurring items from the first half of the year. Despite this, the company saw a 19.2% increase in operating income to €11.688 billion and a 13.1% rise in revenue to €36.550 billion. In Q3 alone, net profit rose by 7.8% to €3.021 billion, with a 20% increase in net income from ongoing activities. The company has revised its financial outlook upwards, anticipating growth in both revenue and earnings per share for 2026.